Coronary Angioplasty Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Left Upper Extremity Pain, Right Coronary Artery Culprit: A Puzzling Path to Aneurysm Discovery
We report a case of an adult harboring a GCA involving the right coronary artery.PMID:38618608 | PMC:PMC11011955 | DOI:10.14797/mdcvj.1287 (Source: Methodist DeBakey Cardiovascular Journal)
Source: Methodist DeBakey Cardiovascular Journal - April 15, 2024 Category: Cardiology Authors: Moath Said Alfawara Vivek Modi Min-Fang Chao Malek Nayfeh Fares Alahdab Mahmoud Alrifai Mouaz Al-Mallah Source Type: research

Drug-Coated Balloon in Acute Coronary Syndromes: Ready for the Prime Time?
AbstractPurpose of ReviewAcute coronary syndromes (ACS) are a major global health concern. Percutaneous coronary intervention (PCI) with new-generation drug-eluting stents (DES) has been endorsed as safe and effective in the management of culprit and non-culprit lesions of ACS. However, permanent metallic implants may have drawbacks, including the need for prolonged dual antiplatelet therapy (DAPT) and the risk of long-term stent-related complications. An alternative approach using drug-coated balloons (DCBs) is gaining growing interest, having the potential of delivering therapy directly to vulnerable plaques, avoiding th...
Source: Current Cardiology Reports - April 15, 2024 Category: Cardiology Source Type: research

Feasibility and Safety of Bridging Antiplatelet Therapy with Cangrelor in Neuro-Oncology: A Preliminary Experience
J Neurol Surg A Cent Eur Neurosurg DOI: 10.1055/s-0044-1785649Antiplatelet therapy is mandatory for prevention of thrombotic events in patients with a recent history of acute coronary syndromes and/or percutaneous coronary interventions. However, if an urgent surgery is required during antiplatelet therapy, a compromise between the ischemic/thrombotic and hemorrhagic risk has to be reached. Different bridging schemes are reported in the literature, but there is no clear consensus on the optimal treatment strategy in terms of efficacy and safety. Although some indications about the perioperative management of antiplatelet t...
Source: Journal of Neurological Surgery Part A: Central European Neurosurgery - April 15, 2024 Category: Neurosurgery Authors: Bertolini, Giacomo Belli, Laura Mazza, Stefania Ugolotti, Pietro Tito Tadonio, Iacopo Ceccarelli, Patrizia Rossi, Sandra Ippolito, Salvatore Tags: Technical Note Source Type: research

Rotational Atherectomy in Women
While ischemic heart disease represents the leading cause of death among both women and men worldwide, gender-related differences in clinical presentation, disease management, response to therapies and outcomes are evident. Identifying and understanding sex-based disparities and remaining cognizant that optimal therapeutic approaches may differ for women and men with coronary disease is a priority in optimizing care for both genders. With respect to coronary revascularization, women referred for percutaneous coronary intervention (PCI) are significantly older than their male counterparts and have a higher prevalence of com...
Source: The American Journal of Cardiology - April 15, 2024 Category: Cardiology Authors: Craig R. Narins Tags: Editorial Source Type: research

Chemokine Fractalkine and Non-Obstructive Coronary Artery Disease-Is There a Link?
Int J Mol Sci. 2024 Mar 30;25(7):3885. doi: 10.3390/ijms25073885.ABSTRACTNon-obstructive coronary artery disease (NO-CAD) constitutes a heterogeneous group of conditions collectively characterized by less than 50% narrowing in at least one major coronary artery with a fractional flow reserve (FFR) of ≤0.80 observed in coronary angiography. The pathogenesis and progression of NO-CAD are still not fully understood, however, inflammatory processes, particularly atherosclerosis and microvascular dysfunction are known to play a major role in it. Chemokine fractalkine (FKN/CX3CL1) is inherently linked to these processes. FKN/C...
Source: Atherosclerosis - April 13, 2024 Category: Cardiology Authors: Aleksandra Stangret Karol Artur Sadowski Konrad Jab łoński Janusz Kochman Grzegorz Opolski Marcin Grabowski Mariusz Tomaniak Source Type: research

Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
AbstractThe use of intravenous antiplatelet therapy during primary percutaneous coronary intervention (PPCI) is not fully standardized. The aim is to evaluate the effectiveness and safety of periprocedural intravenous administration of cangrelor or tirofiban in a contemporary ST-segment elevation myocardial infarction (STEMI) population undergoing PPCI. This was a multicenter prospective cohort study including consecutive STEMI patients who received cangrelor or tirofiban during PPCI at seven Italian centers. The primary effectiveness measure was the angiographic evidence of thrombolysis in myocardial infarction (TIMI) flo...
Source: Journal of Thrombosis and Thrombolysis - April 13, 2024 Category: Hematology Source Type: research

Outcomes of patients with cerebral microbleeds undergoing percutaneous coronary intervention and dual antiplatelet therapy
Conclusion: Although a substantial number of patients who underwent PCI had cerebral microbleeds, at approximately two years of follow-up, intracerebral hemorrhage was very rare in our study population. (Source: Heart and Vessels)
Source: Heart and Vessels - April 12, 2024 Category: Cardiology Source Type: research

Predictors of major adverse cardiac and cerebrovascular events after percutaneous coronary intervention in older adults: a systematic review and meta-analysis
We systematically reviewed and meta-analyzed the predictors of major adverse cardiac and cerebrovascular events (MACE/MACCE) in older adults who underwent PCI. (Source: BMC Geriatrics)
Source: BMC Geriatrics - April 12, 2024 Category: Geriatrics Authors: Arash Jalali, Ali Hassanzadeh, Mohammad Sadeq Najafi, Sepehr Nayebirad, Mohadese Dashtkoohi, Zahra Karimi and Akbar Shafiee Tags: Research Source Type: research

Hemoglobin A1c levels and 1-year mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention
Future Cardiology, Ahead of Print. (Source: Future Cardiology)
Source: Future Cardiology - April 11, 2024 Category: Cardiology Authors: Peyman Izadpanah Tara Dehghanzadeh Armin Attar Alireza Hosseinpour Nima Rahimikashkooli Source Type: research